O2M Technologies
O2M Technologies, LLC develops oxygen imaging devices and services for cancer research, regenerative medicine, and preclinical drug development, anchored by the JIVA-25, the world's first dedicated preclinical oxygen imager using pulsed electron paramagnetic resonance technology. It sells instruments, proprietary contrast agents, and contract research services to academic and pharmaceutical customers.
- Company typePrivate
- Founded2017
- HeadquartersChicago, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What O2M Technologies does
O2M Technologies, LLC is a Chicago-based private company that develops oxygen imaging devices and services for cancer research, regenerative medicine, and drug development. The company's foundational technology is pulsed electron paramagnetic resonance oxygen imaging (EPROI), a non-invasive method that maps absolute tissue oxygen (pO2) at approximately 0.5 mm spatial resolution using a water-soluble, non-toxic trityl spin probe. The company describes itself as the world leader in EPR oxygen imaging and its application to biomedical fields.
O2M's commercial portfolio centers on the JIVA-25®, positioned as the world's first dedicated preclinical oxygen imager, which produces absolute pO2 maps with 1 mmHg sensitivity in 1–10 minutes. The instrument is complemented by a consumables line — Trityl OXO71 and OXO63 water-soluble contrast agents — and by LiteAPM™, a 184-gram transportable small-animal physiological monitor used during imaging and surgery workflows. Together, these products constitute an integrated imaging + consumables + accessories platform for preclinical oxygen measurement.
O2M generates revenue through three streams: one-time sales of JIVA-25 instruments (capital equipment), recurring sales of Trityl contrast agents (consumables), and contract research services delivered through its Oxygen Measurement Core facility, which provides in vitro and small animal in vivo oxygen measurement from sample preparation through publication-quality data. The company pursues a sales-led go-to-market targeting academic and foundation research institutions, cancer research centers, and pharmaceutical and biotech companies. Pricing is quote-based across instruments, consumables, and services and is not publicly disclosed. Cumulative disclosed funding totals approximately $1.2 million across two NSF grants (2018 and 2021); no equity funding, named customers, or revenue figures have been disclosed.
O2M Technologies firmographics
Firmographics- Name
- O2M Technologies
- Legal name
- O2M Technologies, LLC
- Website
- https://o2map.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- O2M Technologies, LLC develops oxygen imaging devices and services for cancer research, regenerative medicine, and preclinical drug development, anchored by the JIVA-25, the world's first dedicated preclinical oxygen imager using pulsed electron paramagnetic resonance technology. It sells instruments, proprietary contrast agents, and contract research services to academic and pharmaceutical customers.
- Ownership category
- akta.pro rank
O2M Technologies industry classification
Industry- Product category
- Preclinical Oxygen Imaging Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417)
- SIC
- Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)
Keywords
Where O2M Technologies is headquartered
LocationHeadquarters
- HQ city
- Chicago
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
O2M Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Scientific Instruments (JIVA-25®): Sale of specialized preclinical oxygen imaging instruments to research institutions and pharmaceutical companies. This represents the primary capital equipment revenue stream.
- Consumables (Trityl Contrast Agents): Recurring revenue from Trityl OXO71 and OXO63 contrast agents sold as powder or stock solution to existing JIVA-25 customers.
- Contract Research Services (Oxygen Measurement Core): Contract research facility offering complete in vitro and small animal in vivo oxygen measurement services — from sample prep through publication-quality data for academic, foundation, and industry partners.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for all products and services |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
O2M Technologies product offering
Product offeringCore offering
O2M Technologies develops and sells the JIVA-25®, the world's first dedicated preclinical oxygen imager, which uses pulsed electron paramagnetic resonance oxygen imaging (EPROI) to non-invasively map absolute tissue oxygen (pO₂) at approximately 0.5 mm resolution. The company complements the instrument with Trityl OXO71 and OXO63 water-soluble contrast agents, the LiteAPM™ small-animal physiological monitor, and the Oxygen Measurement Core contract research service for academic and pharmaceutical partners.
Product overview
O2M Technologies offers a portfolio of oxygen imaging products and services for biomedical research. The core product is the JIVA-25® — the world's first dedicated preclinical oxygen imager that produces absolute tissue oxygen (pO₂) maps at ~0.5 mm resolution using pulsed electron paramagnetic resonance oxygen imaging (EPROI) technology. This is complemented by Trityl OXO71 & OXO63 contrast agents (water-soluble, non-toxic consumables), the LiteAPM™ physiological monitor for small-animal monitoring, and the Oxygen Measurement Core contract research service providing in vitro and in vivo oxygen measurement services for academic and industry partners.
Differentiator
Problem solved
Functional benefit
Products and services
- JIVA-25® The JIVA-25 is the world's first dedicated preclinical oxygen imager. It produces absolute pO₂ maps with 1 mmHg resolution in 1–10 minutes using pulsed electron paramagnetic resonance oxygen imaging (EPROI) and is sold to academic research institutions, foundations, and pharmaceutical/biotech companies for tumor hypoxia, therapy response, and drug development studies.
- Trityl OXO71 & OXO63 Contrast Agents Water-soluble, non-toxic oxygen-imaging Trityl contrast agents (OXO71 and OXO63) sold as powder or stock solution and used with the JIVA-25 instrument for EPR oxygen imaging. These consumables are purchased by existing JIVA-25 customers in academic, foundation, and pharmaceutical/biotech settings as recurring inputs for preclinical oxygen studies.
- LiteAPM™ The LiteAPM is a 184-gram transportable small-animal physiological monitor that tracks temperature and breathing during surgery, imaging, and transfers. It is sold as an accessory to JIVA-25 users and other preclinical imaging laboratories requiring lightweight, transportable vital-sign monitoring for small animals.
- Oxygen Measurement Core The Oxygen Measurement Core is O2M's contract research service that delivers complete in vitro and small animal in vivo oxygen measurement studies on the JIVA-25, spanning sample preparation through publication-quality data output. The service is offered to academic researchers, scientific foundations, and pharmaceutical/biotech industry partners who need EPROI oxygen data without operating the instrumentation themselves.
Quantifiable outcome
- ~0.5 mm spatial resolution for tissue oxygen mapping
- +2 more outcomes
Companies that use O2M Technologies
Customer profileSegments3 records
Ideal customer profiles3 records
O2M Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
O2M Technologies partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights4 records
O2M Technologies competitors and assessment
Company assessmentBroad incumbents
- Bruker Corporation: Bruker is the leading manufacturer of EPR spectrometers and preclinical MRI systems, including ELEXSYS and Biospec product lines that compete with O2M's JIVA-25 in EPR-based measurement for biomedical research. Bruker is a broad incumbent across scientific instruments with overlap in the core technology platform.
- PerkinElmer (Revvity): PerkinElmer/Revvity's life sciences segment supplies preclinical imaging reagents, IVIS optical imaging systems, and laboratory analytical instruments to academic and pharma R&D customers. The company addresses an overlapping customer base with broader portfolio positioning.
Direct peers
- LI-COR Biosciences: LI-COR manufactures preclinical optical and infrared imaging systems (Pearl Trilogy, Odyssey CLx) used in small-animal cancer and metabolism research. Both companies sell dedicated preclinical imaging capital equipment plus consumables to overlapping academic and pharma research customers.
- Aspect Imaging: Aspect Imaging produces compact, easy-to-site preclinical MRI systems (M-series) targeting the same dedicated preclinical imaging niche as O2M's JIVA-25, with comparable positioning around accessible, dedicated bench-top form factors for biomedical research labs.
- MR Solutions: MR Solutions designs preclinical MRI and PET/MR systems for small-animal imaging used in cancer and drug development research, overlapping with O2M's preclinical imaging value proposition and academic/biopharma customer base.
- Mediso Medical Imaging Systems: Mediso manufactures preclinical PET, SPECT, and CT imaging systems (nanoScan) used by cancer researchers and pharma drug development groups globally. It addresses the same dedicated preclinical imaging category with multi-modality instrumentation.
- Oxford Instruments (Andor): Oxford Instruments Andor division supplies scientific detectors, spectroscopy cameras, and microscopy imaging platforms used in biomedical EPR and oxygen research. Both companies serve the analytical/measurement instrumentation workflow for biomedical labs.
Emerging players
- Miltenyi Biotec: Miltenyi Biotec provides preclinical imaging and cell-analysis workflows (MACS, gentleMACS, ultra-high-field MRI) for translational and preclinical research. It overlaps with O2M's pharma/biotech translational customer base and dedicated instrument sales motion.
- Active Spectrum: Active Spectrum produces bench-top EPR spectrometers for chemistry, catalysis, and emerging biomedical applications. It overlaps with O2M's EPR core-technology base and dedicated bench-top preclinical instrument positioning.
Regional players
- Scintica Instrumentation: Scintica is a specialized distributor and integration partner for preclinical imaging modalities (ultrasound, photoacoustic, MRI) into the North American research market, comparable to O2M's dedicated preclinical instrument go-to-market through direct academic/pharma sales.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
O2M Technologies social profiles
Digital presenceO2M Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
O2M Technologies leadership team
Management profileNumber of profiles
Profiles1 record
O2M Technologies funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
O2M Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about O2M Technologies
What does O2M Technologies do?
O2M Technologies develops and sells the JIVA-25®, the world's first dedicated preclinical oxygen imager, which uses pulsed electron paramagnetic resonance oxygen imaging (EPROI) to non-invasively map absolute tissue oxygen (pO₂) at approximately 0.5 mm resolution. The company complements the instrument with Trityl OXO71 and OXO63 water-soluble contrast agents, the LiteAPM™ small-animal physiological monitor, and the Oxygen Measurement Core contract research service for academic and pharmaceutical partners.
Is O2M Technologies a public or private company?
O2M Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was O2M Technologies founded?
O2M Technologies was founded in 2017. It employs 11 to 50 people.
Where is O2M Technologies based?
O2M Technologies is headquartered in Chicago, United States, in the North America region.
How does O2M Technologies make money?
Three revenue lines are on record. Scientific Instruments (JIVA-25®) is the primary driver. The others are consumables (Trityl Contrast Agents) and contract Research Services (Oxygen Measurement Core).
Who are O2M Technologies's main competitors?
Broad incumbents on record are Bruker Corporation and PerkinElmer (Revvity). Direct peers are LI-COR Biosciences, Aspect Imaging, MR Solutions, Mediso Medical Imaging Systems and Oxford Instruments (Andor). Emerging players are Miltenyi Biotec and Active Spectrum. Scintica Instrumentation is listed as a regional player.
Does O2M Technologies have an API?
No public API is recorded for O2M Technologies.
What industry is O2M Technologies in?
O2M Technologies's product category is Preclinical Oxygen Imaging Instruments. Its primary akta.pro industry code is HLAHAGAI, Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate). Its NAICS code is 334516 and its SIC code is 3826.